The Prevalence Of Elevated Carcinoembroynic Antigen At Gorgan South-East Caspian Sea Of Northern Iran

The aim of this study was to find out the prevalence of CEA elevation among subjects, regardless of the contradictory arguments about the senstivity and specificity of this tumor marker. Carcinoemroyonic antigen (CEA) is a tumor marker widely practiced to screen, diagnose, monitor and follow-up patients with gastrointestinal, and particularly colorectal tumor. This tumor marker is not a specific antigen for colorectal carcinoma and its concentration may be elevated in other forms of carcinomas, such as breast, ovary, liver and pancreas, but still its elevated serum concentration is a valuable index widely used in clinical practice for gastrointestinal carcinogen. The data for this retrospective study obtained from data base of Danesh medical diagnostic laboratory in Gorgan located in northern Iran. The conclusion of the findings of this investigation indicated that 17.39% suspected patients had tumor marker for a particular carcinoma, the CEA elevated level should be considered either for tumor or its recurrence. The findings of this study indicated that even among all controversial arguments about CEA as a specific and alarming tool to both the patients and clinician, which is the least contribution CEA level can offer in cancer patient management.